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Abstract The viscoelastic lumbar disk prosthesis-elastic
spine pad (LP-ESP) is an innovative one-piece deform-
able but cohesive interbody spacer providing 6 full degrees
of freedom about the 3 axes, including shock absorption. A
20-year research program has demonstrated that this con-
cept provides mechanical properties very close to those of a
natural disk. Improvements in technology have made it
possible to solve the problem of the bond between the
elastic component and the titanium endplates and to obtain
an excellent biostability. The prosthesis geometry allows
limited rotation and translation with resistance to motion
(elastic return property) aimed at avoiding overload of the
posterior facets. The rotation center can vary freely during
motion. It thus differs substantially from current prosthe-
ses, which are 2- or 3-piece devices involving 1 or 2
bearing surfaces and providing 3 or 5 degrees of freedom.
This design and the adhesion-molding technology differ-
entiate the LP-ESP prosthesis from other mono-elastomeric
prostheses, for which the constraints of shearing during
rotations or movement are absorbed at the endplate inter-
face. Seven years after the first implantation, we can doc-
ument in a solid and detailed fashion the course of clinical
outcomes and the radiological postural and kinematic
behavior of this prosthesis.
Keywords Disc arthroplasty  Disc replacement
biomechanics  Motion preservation  Disc degeneration 
Low back pain  Spinal alignment
Introduction
Because of its impairment of patients’ personal, social, and
professional lives, degenerative disk disease has become an
important public health problem with multiple dimensions.
The current therapeutic strategy remains controversial and
is also a medical and surgical challenge. Conservative
treatment, mostly based on physical therapy, constitutes the
first-line approach, but persistent symptomatic disease may
be treated surgically in selected patients [1–3]. Lack of
pain relief, stiffening of the lumbar spine, nonunion, sag-
ittal balance misalignment, bone graft donor site morbidity,
and, last but not least, adjacent segment disease are the
pitfalls of intervertebral fusion that led to the idea of total
disk replacement (TDR) [4–7]. Since 1966 and Fernstro¨m’s
first TDR implantation [8], many designs and concepts
have been proposed [9–18]. The devices are usually
articulated implants, and their mobility depends on the
designs of the bearing surfaces. Ball-and-socket two-piece
prostheses have 3 degrees of freedom in every rotation
around a single fixed center of rotation. Three-piece devi-
ces allow additional translation components, providing 5
degrees of freedom. Articulated TDRs have demonstrated
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their clinical utility in several patient series. Specifically,
the non-inferiority of TDR versus fusion is now generally
accepted [13–15, 19]. However, in vitro testing of the two
types of implants reveals that both designs have biome-
chanical advantages and limitations.
Because the healthy human intervertebral disk has a
deformable elastic structure with 6 degrees of freedom,
elastomeric one-piece intervertebral prostheses might be
the most physiological implant for mimicking physiologi-
cal levels of shock absorption and flexural stiffness.
Designing such a device is challenging, especially when we
remember the Acroflex prostheses: The elastic rubber
failed so rapidly in vivo that only 28 were implanted in all
[20, 21].
The LP-ESP (lumbar disk prosthesis-elastic spine pad)
was developed over a 20-year period. Improvements in
technology have made it possible to solve the problem of
the bond between the elastic component and the titanium
endplates. After successful in vitro and in vivo evaluation,
the LP-ESP has been authorized for clinical use in Europe
since 2005. The goal of this paper is to present its inno-
vative concept and the clinical results and radiological
outcomes over its 7 years of use.
Implant design
The design of the LP-ESP prosthesis is based on the
principle of the silent block bush (Fig. 1). The LP-ESP is
a one-piece deformable implant including a central core
made of silicone gel with microvoids and surrounded by
polycarbonate urethane (PCU) securely fixed to titanium
endplates (Fig. 2). The endplates have five anchoring pegs
to provide primary fixation and are covered by a textured T
40 titanium layer (60 lm thick) and hydroxyapatite to
improve bone ingrowth.
Depending on the size, the titanium endplates differ in
thickness and angulation. The prostheses are available in
two thicknesses (10 and 12 mm), each with 3 angles of
lordosis (7, 9, and 11). Regardless of the model, how-
ever, the mechanically active cushion and the mechanical
properties of the prosthesis are the same: The differences in
thickness of the lordotic angle do not affect the prosthesis’s
mobility or its cushioning, even shock-absorbing, effect.
Accordingly, the peripheral cushion (that is, the annu-
lus) is securely fixed to the titanium alloy endplates by
adhesion-molding technology. This attachment is rein-
forced by a peripheral groove without the addition of glue.
This process of fixation avoids fluid infiltration and the risk
of fatigue fractures of the interface, despite the very dif-
ferent mechanical properties of the polymer and the metal
endplates. The PCU annulus is stabilized by supplementary
pegs located on the internal surface of both metal end-
plates. The geometry and position of the pegs, between the
peripheral groove and the central area of the endplates,
were planned to control rotational mobility (Fig. 3). The
polymer molding was designed to prevent all direct contact
between the upper and lower pegs.
The core or nucleus is composed of a compressible
silicone structure containing isobutane microbubbles. This
Fig. 1 The design of the
LP-ESP prosthesis is based on
the principle of the silent block
bush
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core is injected after the annulus surrounding it has been
molded. Two titanium caps allow the core to be contained
at the moment of the injection. These two pieces are firmly
secured to the titanium plates: They also play a mechanical
role by their contactless fit, because they contribute to
limiting shearing during anteroposterior and mediolateral
translation. The cushioning and compressing effects are
obtained on the one hand by the contactless interlocking of
the male and female caps and, on the other hand, by
crushing the annulus between the two metal plates. The
same components limit the shearing effect when the end-
plates are inclined to the horizontal.
On the whole, in the LP-ESP, the constraints of the inter-
face between the PCU cushion and its titanium seating are
reduced. These are principally constraints of compression:
• between the exterior of the male cap and the interior of
the female cap for translations;
• between the pegs for the rotation;
• between the titanium endplates for flexion.
Fig. 3 The peripheral cushion
(the annulus) is securely fixed to
the titanium alloy endplates by
adhesion-molding technology.
This attachment is reinforced by
a peripheral groove without the
addition of glue. The PCU
annulus is stabilized by
supplementary pegs located on
the internal surface of both
metal endplates. The cushioning
and compressing effects are
obtained on the one hand by the
contactless interlocking of the
male and female caps and, on
the other hand, by crushing the
annulus between the two metal
plates
Fig. 2 The LP-ESP is a one-
piece deformable implant
including a central core made of
silicone gel with microvoids and
surrounded by polycarbonate
urethane (PCU) securely fixed
to titanium endplates
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The principle of the LP-ESP makes it possible to
reproduce the anisotropy of the healthy disk, and the design
allows modification of the return torque (without modify-
ing the other parameters of the prosthesis. For example:
• bringing the pegs closer together increases stiffness in
rotation without modifying either translation or
compression;
• diminishing the clearance between the male and female
caps increases the stiffness of translation without
modifying either rotation or compression;
• modifying the ratio between the small and large
diameters of the elliptic form of the cushion changes
the ratios of the return torques between flexion/exten-
sion and lateral flexion without modifying stiffness in
compression or rotation.
Design stages
After an initial patent application in 1994 by R. ROY
CAMILLE, different avenues of research were explored,
with the scientific expertise of the CEA (Commissariat a`
l’Energie Atomique, Fontenay aux Roses, France) and the
industrial expertise of FH Industry for further R & D
(Heimsbrunn, France). The preliminary stages involved
optimizing the choice of PCU, the development of the
attachment of the annulus to the metal endplates without
chemical adhesives, the definition of the pegs and caps, and
the implementation of reliable techniques for polymer
molding and injection. Biocompatibility tests were per-
formed by BIOMATECH, a subsidiary of NAMSA
(Northwood, Ohio, USA).
Human implantation began in 2004 with the first gen-
eration of LP-ESP implants, which used endplates with-
out lordosis (40 implantations, all complying with the
Huriet Act, which defines French ethical requirements). A
second generation of implants with lordotic endplates (7,
9, and 11) was introduced in 2005—LP-ESP 1. A final
change was made to the PCU annulus in 2006: Its
periphery is no longer rectilinear but was recessed some-
what during the molding process. This change did not
modify the attachment of the cushion of the LP-ESP 2
prosthesis but made it possible to reduce its stiffness during
compression by 30 % without changing its characteristics
for flexion/extension, lateral incline, or rotation (Fig. 4a–c).
This ESP prosthesis received CE marking in 2005, making it
the first elastomeric lumbar prosthesis to be validated and
authorized for marketing.
Mechanical properties
The ‘‘silent block bush’’ design of the LP-ESP prosthesis
avoids the disadvantage of centers of rotation that are fixed
or controlled by the implant design, as observed in disk
prostheses based on an articulated design. In addition, in
each direction solicited, the prosthesis offers resistance that
increases with the amplitude of the movement. In this
sense, the LP-ESP cannot be compared to first-generation
implants. It meets the mechanical criterion of 6 degrees of
freedom and provides a cushioning effect while restoring
elastic recovery properties. Its mechanical properties are
close to those reported in the literature for the normal disk
(see Table 1).
Biomechanical assessment
The originality of the concept of the ESP prosthesis led to
innovative and intense testing of various sorts.
Fig. 4 a First generation of lumbar ESP (2004): endplates without lordosis. b Second generation of lumbar ESP (2005): The shape of the
endplates provides lordosis. c Last generation of lumbar ESP (2006): anterior recess in the PCU annulus to reduce stiffness during compression




After continuous compression to 1,250 kN for 2,928 h
(122 days), the height loss was 0.2 mm. In the 8 h fol-
lowing load removal, the residual height loss was 0.1 mm.
Influence of the pegs included in the PCU annulus
to control rotations
Tests were performed for combined compression and
rotation: The pegs included in the PCU annulus absorb
approximately 50 % of the torque.
Assessment of the cohesion of the prosthetic cushion
and the metal endplates
The tests were performed for anteroposterior and medio-
lateral exertion applied to one of the metal endplates, with
the other plate attached to the test machine (Fig. 5). For
implants 12 and 10 mm thick, respectively, a force of 450
and 800 N was required to obtain a gap of 1 mm between
the 2 endplates in the anteroposterior direction and 550 and
600 N in the mediolateral direction.
Maximum compression tests
These tests were inspired by the experimental protocol of
Virgin [26], who stated that a natural healthy disk is irreversibly
injured by a load of 3–11 kN. After application of a force of
4,800 N (100 h) and then 9,200 N (64 h), we did not observe
irreversible destruction of the implants. Compression tests and
then compression–shearing at an angle of 45 were performed
on the same samples to obtain successive compressions of 2, 3,
and 6 mm. These tests show the implant’s excellent tolerance
of these compression–shearing mechanisms.
Tests to validate the final stage of coating on the exterior
side of the metal plates
Adding a further final coating of porous titanium and
spraying hydroxyapatite on the implant in its permanent
form causes its temperature to rise. During the coating
process, the disc is cooled by compressed air so that the
ambient temperature remains stable at 21 C. Tests were
performed to verify the absence of any effect from this rise
on the mechanically active cushion in view of the known
risk of PCU deterioration at 120 C. These tests demon-
strated that the temperature did not reach a level of risk to
the PCU (Fig. 6).
Table 1 Comparison of the
mechanical properties of the
LP-ESP 2 prosthesis with
those of the natural disk
Pure moments applied in increments
up to a maximum value of 10 N/m
References Level Natural disk LP-ESP
2 prosthesis
Flexion–extension Panjabi [22] L4/L5 6 6
L5/S1 4
Campana [24] L1/L2 4
L4/L5 7
Yamamoto [23] L1/L2 5
L4/L5 7.5
Lateral flexion Panjabi [22] L4/L5 4 2.5
L5/S1 2
Campana [24] L1/L2 4.1
L4/L5 6.1
Yamamoto [23] L1/L2 5
L4/L5 5.7
Torsion Panjabi [22] L4/L5 2 2
L5/S1 1
Campana [24] L1/L2 2.4
L4/L5 3.4
Yamamoto [23] L1/L2 2.3
L4/L5 2.2
Axial compression Gardner-Morse [25] 2,420 N/mm 2,300 N/mm
Variable according to the loading
speed, values retained for 0.1 m/s
Virgin [26] 3,000 N/mm
Kemper [27] 1,835 N/mm
Bouzakis [28] 1,700 N/mm
Elastic recovery Yes Yes
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Fatigue and wear tests
Wear tests were conducted in a 3-axis motion simulator
according to the following protocol (Fig. 7):
• Series of 10 million cycles of flexion, extension, and
lateral tilting
• Frequency = 4 Hz
• Loads of 135–1,350 N
• Inclination of the prosthesis at 45 to reproduce the
sagittal orientation of the disk in functional situations
• In a demineralized water bath at 37 C
Tests have even been extended to 40 million cycles
without any observation of signs of mechanical failure. No
loss of cohesion was seen and stiffness remained stable
(Fig. 8). The residual gap between the metal endplates was
0.55 mm after 20 million cycles and 0.78 mm after
40 million cycles (Fig. 9). Loss of mass after 20 million
cycles was less than 0.5 % (very low absorption of saline
solution and slight degradation of the endplates coating).
Biostability tests
This test was conducted according to the requirements of
IS0 standard 10993-13/biological evaluation of medical
devices, Part 13: Identification and quantification of the
decay products of polymer-based medical devices.
The biostability of the implant was assessed by analysis
of the particles collected during the filtration of the
demineralized water bath, after a wear test of 10 million
Fig. 5 Assessment of the cohesion of the prosthetic cushion and the metal endplates: The tests were performed for mediolateral and
anteroposterior exertion applied to one of the metal endplates, with the other plate attached to the test machine
Fig. 6 Thermosensitive
indicators confirm that the
temperature of the polyurethane
remained below 65 C. The
appearance of the polymer
remains unchanged
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cycles under a load of 1,350 N. This study used a scanning
electron microscope (SEM LEO1455VP), equipped with
an energy-selective spectrometer (EDS OXFORD). No
particles from the component materials of the prosthesis
were found.
The tests looking for salted out or released matter showed
the emission of\1 mg/kg methylene diphenyl 4-4 diisocy-
anate and of 64.9 mg/kg of 4-4 methylene diamine. These
results are consistent with the data in the literature [29].
PCU aging test
The specific PCU (Bionate 80A) used for the LP-ESP
prosthesis is not oxidized during storage (DSNM Bio-
medical The Netherlands, according to master file
MAF844). Kurz demonstrated that 5 years of shelf aging
has little effect on the mechanical properties of the PCU
and concludes that the bionate 80A material has greater
oxidative stability than ultra-high molecular weight poly-
ethylene following gamma irradiation in air and exposure
to a severe oxidative challenge [30]. Tests were performed
after artificial aging in water at 80 C followed by
10 million compression cycles at loads ranging from 150 to
1,250 N. In the absence of published standards in the lit-
erature, the temperature was determined in comparison
with that recommended for aging plastics, including
UHMWPE (ASTM standard F 2003: Accelerated aging of
ultra-high molecular weight polyethylene after gamma
irradiation in air), and the axial load was that recommended
by ISO standard 18192 (Intervertebral spinal disk pros-
theses—Part 1: Loading and displacement parameters for
wear testing and corresponding environmental conditions
for test) for wear tests. It was not observed significant
changes in the stiffness of the implants tested.
No modification of the Fournier transform infrared
spectrum or any modification of the mean molecular
weight (ASTM standard D 5296) was observed (Fig. 10).
The chemical composition and organization of the atomic
bonds, therefore, remained identical because oxidation or
natural cross-linkage would have modified the atomic
organization and thus the spectrum. These results are
consistent with the literature [29].
Biocompatibility tests
All the materials were studied separately and in their final
assembly, meeting the specifications for biocompatibility
tests described in ISO standard 10993 (Biological Evalu-
ation of Medical Devices). Tests were performed by
Biomatech (Chasse-sur-Rhoˆne, France).
Cytotoxicity test according to ISO standard 10993-5
Sensitization test according to ISO standard 10993-10
Test of irritation or intradermal reaction according to
ISO standard 10993-10; acute systemic toxicity accord-
ing to ISO standard 10993-11 Chromosomal genotoxi-
city (heart test and chromosomal anomalies according to
ISO standard 10993-3)
The implants also meet the criteria of the FDA’s
subacute sensitization test (following FDA—Guidelines
for Toxicity Tests Chapter IV).
Clinical results
Evaluation process
As of today, more than 2000 LP-ESP II prostheses have
been implanted. No complication related to the materials
Fig. 7 Wear tests were
conducted in a 3-axis motion
simulator (frequency = 4 Hz,
loads of 135–1,350 N). The
inclination of the prosthesis was
45 to reproduce the sagittal
orientation of the disk in
functional situations. The gap
between the metal plates was
measured after each series of
10 million cycles
Fig. 8 Stiffness in compression
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has been reported. The clinical experience can be illustrated
by the analysis of a prospective series of 120 patients who are
representative of the current use of the ESP implant (2 sur-
geons JYL and JPR) with a complete 2-year follow-up. There
were 73 women and 47 men in this group. The average age
was 42 (27–60). The average body mass index (BMI) was
24.2 kg/m2 (18–33). The implantation was single level in
89 % of cases; 134 ESP prostheses were analyzed.
The functional results were measured using:
• the Oswestry Disability Index (ODI): a 15 % improve-
ment of the ODI at 2-year follow-up was considered as
a good result according to previously published criteria
[31, 32].
• the SF-36, with distinguishing the physical component
(PCS) and the mental component (MCS),
• the GHQ 28 (General Health Questionnaire) that was
used for psychological assessment [33],
• the visual analogic scale (VAS) regarding back pain
[34].
Clinical data and X-rays were collected at the preop-
erative time and at 3, 6, 12, 24, and 36 months postop.
Paired t-test were used for comparing the outcomes at
each time point post-op to their pre-operative values. The
level of significance was set for p \ 0.05. The radiolog-
ical images were digitized using the dedicated scan Vi-
darTM Twain 32 (Vidar Corporation) and analyzed using
the Dicomeasure software (Viewtec, Maisons-Alfort,
France) [35]. The analysis was performed by a single
observer (AB) who was independent from the selection of
patients and from the surgical procedure. On lateral views
in standing position were measured the sacral slope (SS),
the pelvic tilt (PT), and the segmental lordosis (SL).
Mobility of the prosthesis, the upper adjacent level, and
L1S1 segments were measured on flexion/extension X-ray
(Fig. 11). One recall that the inferior limit for the criteria
of mobility is 3 for some authors [36] and 5 for others
[37–39]. The difficulty in obtaining strict lateral views of
the spine limited the radiological analysis of kinematic to
67 patients (74 prostheses). In accordance to the work of
Wong et al. [40, 41] and Lee et al. [42], the interpretation
of the mobility of the prosthetic level has been considered
in reference to the age and the global mobility of the
L1S1 segment.
Fig. 9 Evolution of the lag of
the endplates plates
Fig. 10 Comparison of infrared spectra after/before PCU aging: No change in the spectra was observed
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Clinical results
The mean operative time was 92 min (standard deviation,
SD: 49 min). The mean blood loss was 73 cc (SD:
162 cc).We did not observe device-related specific com-
plications. The clinical results are reported in Tables 2
and 3. All clinical outcomes significantly improved at
every time points when compared to the pre-operative
status. The series demonstrated an improvement of
18.7 % for GHQ, 26.6 % for SF 36 PCS, and 16.4 % for
SF 36 MCS. At the final follow-up, an ODI improvement
[5 points is observed in 76 % of the cases. ODI
improvement of 15 is 85 % at 24 months and 90 % at
36 months. ODI improvement of 25 is 85 % at 24 and
36 months.
Fig. 11 Measurement of lumbopelvic parameters and calculation of
range of motion on flexion/extension X-rays. L.L. lumbar lordosis,
A.S.S.L. adjacent segment segmental lordosis, D.A.S.L. disc arthro-
plasty segmental lordosis, S.S. sacral slope, P.I. pelvic incidence, P.T.
pelvic tilt, L.S.A.E. lumbar sagittal angle for extension, L.S.A.F.
lumbar sagittal angle for flexion, A.S.S.A.E. adjacent segment sagittal
angle for extension, A.S.S.A.F. adjacent segment sagittal angle for
flexion, D.A.S.A.E. disc arthroplasty sagittal angle for extension,
D.A.S.A.F. disc arthroplasty sagittal angle for flexion: D.A.S.A.F.
Intervertebral flexion–extension angle is calculated according to
Wong [40, 41]: (D.A.S.A.E)–(D.A.S.A.F.) for the arthroplasty level.
(A.S.S.A.E.)–(A.S.S.A.F.) for the adjacent level
Table 2 Description of the different clinical evaluations performed
Mean ± SD PREOP 3 months 6 months 12 months 24 months
VAS 6.6 ± 1.7 3.7 ± 1.9 3.4 ± 2.1 3.5 ± 2.3 3.4 ± 2.4
ODI (%) 47.6 ± 14.6 30.3 ± 17.6 24.5 ± 17.6 21.8 ± 16.3 20.6 ± 17.3
GHQ 28 64.2 ± 15.6 52.5 ± 14.7 52.7 ± 15.8 52.2 ± 15.4 50.6 ± 15.4
SF 36 PCS (%) 32.4 ± 34.8 48.4 ± 39 51.9 ± 39.3 55.6 ± 39.8 59 ± 39.2
SF 36 MCS (%) 42.3 ± 34.0 50.8 ± 34.6 52.8 ± 35.6 53 ± 36.3 58.7 ± 34.6
Table 3 Improvement of the Oswestry Disability Index (ODI) in
reference to the preoperative status (in % of the population)
3 months 6 months 12 months 24 months
ODI improvement
of 15 %
72 % 82 % 85 % 85 %
ODI improvement
of 25 %
59 % 75 % 82 % 83 %
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In the series, 89 % of patients had a good or excellent
result at 3 months, 88 % at 6 and 12 months, and 93 % at
24 months.
Radiological outcome
Tables 4 and 5 summarize the changes in the radiological
parameters of sagittal balance and the variations of range of
motion (ROM) over time.
More than 3 of ROM is observed in 66 % of the
prosthesis, and more than 5 in 60 % of the implants.
According to the previous publications of Wong et al. [40,
41], we correlated the ROM observed at the disc replace-
ment level with the physiological mobility in relation to the
age of the patients and the global lumbar mobility. In the
age group corresponding to our population, the physio-
logical L1S1 global mobility is 30, mean L4L5 ROM is
4.5, and mean L5S1 ROM is 2.5. In the present series,
L1S1 global mobility was 28, mean L4L5 ROM 4.6, and
mean L5S1 ROM 2.7.
Discussion
The viscoelastic LP-ESP prosthesis achieves 6 degrees of
freedom including vertical translation; it provides a cush-
ion and may allow shock absorption. A 20-year research
program has demonstrated that this concept provides
mechanical properties very close to those of a natural disk.
The geometry of the implant allows limited rotation and
translation with resistance to motion aimed at avoiding
overload of the posterior facet joints. The center of rotation
can vary freely during motion.
It thus differs substantially from other current prosthe-
ses, which are 2- or 3-piece devices involving 1 or 2
bearing surfaces and providing 3 or 5 degrees of freedom,
with no or very little resistance, and no elastic return. This
design and the adhesion-molding technology differentiate
the LP-ESP prosthesis from other mono-elastomeric pros-
theses, for which the constraints of shearing during rota-
tions or movement are absorbed at the plastic/titanium
interface because of the molding technology used in their
design. The attachment is obtained by the penetration of
the polymer through small holes in the endplates. This
process creates multiple interfaces and potential fatigue
lesions of the anchoring mechanism due to inhomogeneous
loading during flexion–extension, lateral inclination, and
rotation. Thus, in these designs, the plastic mono-block
cushion secured to the titanium plates flows into the space
between them during compression, creating an area of
friction and wear.
In addition, the biostability of the implant was demon-
strated: No particles from the component materials of the
prosthesis were found after a wear test of 10 million cycles
under a load of 1,350 N. These experimental data should be
considered in relation to previously reported results from
Nechtow et al. [55] of wear rates of 16.59 ± 0.96 mg/million
cycles for ProDisc-L and 19.35 ± 1.16 mg/million cycles
for Charite, and from Grupp et al. [56] of wear rates ranging
from 0.14 ± 0.06 mg/million cycles to 2.7 ± 0.3 mg/mil-
lion cycles for Active L. Moreover, the size and morphology
of the UHMWPE particulates observed in these studies are
similar to those described in total hip and knee replacements
[57], the osteolytic potential of which is well known.
Seven years after the first implantation, we can docu-
ment in a solid and detailed fashion the course of clinical
outcomes and the radiological postural and kinematic
behavior of this prosthesis. We acknowledge that more
studies with more patients and more follow-up would be
useful in the future to assess long-term reliability.
Table 4 Radiological parameters of sagittal balance in standing position over time (mean ± SD)
PREOP 3 months 6 months 12 months 24 months
Pelvic incidence (PI) 54.8 ± 8
Sacral slope (SS) 40.4 ± 7.2 41 ± 6.6 40.6 ± 6.8 41.2 ± 6.2 41.4 ± 6.8
Pelvic tilt (PT) 14.3 ± 7.3 11.8 ± 7 12.3 ± 6.2 12.4 ± 6.7 12 ± 7
Lumbar lordosis 55.8 ± 10 58.5 ± 12.5 59.2 ± 11.3 59.4 ± 13.5 58.3 ± 13.1
Table 5 Range of motion (ROM) of the prosthesis, of the upper adjacent disk, and of the lumbar spine L1S1 over time. (mean ± SD)
3 months 6 months 12 months 24 months
ROM of the instrumented level 4.1 ± 2.4 4.7 ± 2.8 6.0 ± 3.4 5.3 ± 3.2
ROM of the upper adjacent level 4.9 ± 3.2 6.0 ± 4.7 7.9 ± 5.2 6.2 ± 4.1
ROM of the lumbar spine 24.3 ± 14. 27.9 ± 17.9 34.6 ± 16.3 27.5 ± 17.2
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Nonetheless, the series reported here describe the outcomes
that might be expected by surgeons and patients over the
first 7 years. These encouraging results are basically
comparable to the clinical results reported with the Prodisc
II [43], the SB Charite, [44], as reported in Table 6.
Sagittal parameters showed no major imbalance in
spinal posture. These results are consistent with those
reported in the literature with articulated prostheses by
Chung et al. [52] and Tournier et al. [36, 53]. We note that
publications do not appear to report significant sagittal
misalignments after prosthetic implantation, whereas lum-
bar fusion may deleteriously alter the sagittal balance of
the spine, including a decrease in the SS and lumbar lor-
dosis [6, 7]. The increased segmental lordosis might be
related to the lordotic shape of the prosthesis but also
probably to the fact that arthroplasty, in contrast to fusion,
allows the lumbar spine to find a new balance spontane-
ously. It has not yet been demonstrated, however, that this
self-adaptation of the sagittal balance protects against
adjacent-level degeneration. Unlike arthrodesis, the pres-
ervation or restoration of some mobility with a total disk
replacement aims at limiting overload of the adjacent
levels.
The optimal ROM after TDR for limiting adjacent
segmental disease has not yet been established. Huang
et al. [54] reported a series of 42 Prodisc I implantations
with 8.7 years of follow-up, and 24 % of the junctional
levels showed radiological signs of degeneration. In their
study, the mean ROM of the disk prostheses adjacent to
junctional disease was significantly lower than the mean
ROM of the prostheses adjacent to a radiologically normal
disk, that is, 1.6 versus 4.7. Prevalence of junctional
degeneration was 0 % among patients with ROM of 5 or
more and 35 % among those with less than 5. The
authors did not conclude that 5 was the trigger value for
avoiding adjacent degeneration, as 65 % of patients with
less than 5 did not develop adjacent segmental degen-
eration. In our series, the LP-ESP device provides
mobility levels similar to those with articulated prostheses
such as Prodisc, which vary according to the series from
3.8 to 13.2 [52, 54]. Because of the normal variation of
spinal motion of subjects in different age ranges, inter-
pretation of ROM of disc prostheses should be careful and
mainly about the minimum and maximum values for
flexion–extension. As the population concerned by lumbar
disc replacement cannot be compared to a group of young
healthy subjects regarding the motion profile, we suggest
that the reference for ROM should take into account the
global lumbar mobility as well as the age of the patients
to analyze more accurately the functional outcome of
implants. Taking into account these parameters, the
average values for flexion–extension observed in this
series are in agreement with previously published refer-
ence data [40–42].
We recognize that assessing spinal kinematics with
static X-rays in flexion and extension is subject to bias,
given the same-day variations due to inconsistent effort
during flexion/extension [58]. Nonetheless, flexion/exten-
sion X-rays are easily available and cause less irradiation
than continuous motion analysis with in vivo fluoroscopy.
Conclusion
The concept of the LP-ESP prosthesis is different from
that of the articulated devices currently used in the lumbar
spine. This innovative one-piece deformable but cohesive
interbody spacer provides 6 full degrees of freedom about
the 3 axes. In addition, the elastic return property provides
a potential protection for the posterior facet joints.
The 7-year clinical experience provides encouraging
clinical results about pain, function, kinematic behavior,
and radiological sagittal balance after implantation of the
LP-ESP.
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Table 6 Mobility described in
the literature of implants
restoring more than 5 of
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Gioia [45] 2007 2 Charite´ III 8 10.3 8 8.7
Bertagnoli [46] 2005 2 Prodisc – – – 6.5
Guyer [47] 2009 2 Charite´ – 6.5 6 6.3
5 – 6 6.3 6.2
David [48] 1993 1 Charite´ 2 9.4 6.4 5.9
Siepe [49] 2007 1 Charite´ III – 7.2 5.9 6.5
Zigler [50] 2012 5 Prodisc – – – 7.7
Delamarter [51] 2011 2 Prodisc-L 7.8 6.2 7.0
The present series 2012 2 LP-ESP – 8.2 7.6 7.9
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